MedTrace Logo

Double j Stent Related Symptoms

NCT07447518 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 535

Last updated 2026-03-03

No results posted yet for this study

Summary

In urology, ureteral stents are used to treat obstructive diseases. Hematuria (54%), fever, discomfort, and lower urinary system symptoms are the predominant symptoms related to ureteral stent.

Conditions

  • Lower Urinary Tract Symptoms

Interventions

DRUG

Tadalafil 5mg

once daily 5mg

DRUG

solidosin

once daily

DRUG

Solfenacin

once dialy

DRUG

Mirabegron

once daily

DRUG

Placebo

once daily

Sponsors & Collaborators

  • Kafrelsheikh University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-22
Primary Completion
2023-01-01
Completion
2023-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07447518 on ClinicalTrials.gov